» Articles » PMID: 19509100

Cytokine and Cytokine-like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications

Overview
Specialty Endocrinology
Date 2009 Jun 11
PMID 19509100
Citations 256
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Recent developments indicate that pathophysiological mechanisms leading to beta-cell damage, insulin resistance, and the vascular complications of diabetes include an activation of the inflammation cascade, endothelial dysfunction, and procoagulant imbalance. Their circulating biomarkers may therefore provide opportunities for early diagnosis and targets for novel treatments.

Evidence: Circulating biomarkers of these pathways such as TNFalpha, IL-6, C-reactive protein (CRP) (inflammation), vascular cellular adhesion molecule-1, interstitial cellular adhesion molecule-1, E-selectin, von Willebrand factor (endothelial dysfunction), plasminogen activator inhibitor-1, fibrinogen, P-selectin (procoagulant state), and adiponectin (antiinflammation) may be associated with development of both type 1 and type 2 diabetes and some studies, particularly in type 2 diabetes, have demonstrated that certain biomarkers may have independent predictive value. Similarly studies have shown that these biomarkers may be associated with development of diabetic nephropathy and retinopathy, and again, particularly in type 2 diabetes, with cardiovascular events as well. Finally, the comorbidities of diabetes, namely obesity, insulin resistance, hyperglycemia, hypertension and dyslipidemia collectively aggravate these processes while antihyperglycemic interventions tend to ameliorate them.

Conclusions: Increased CRP, IL-6, and TNFalpha, and especially interstitial cellular adhesion molecule-1, vascular cellular adhesion molecule-1, and E-selectin are associated with nephropathy, retinopathy, and cardiovascular disease in both type 1 and type 2 diabetes. Whereas further work is needed, it seems clear that these biomarkers are predictors of increasing morbidity in prediabetic and diabetic subjects and should be the focus of work testing their clinical utility to identify high-risk individuals as well as perhaps to target interventions.

Citing Articles

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.

Ciobarca D, Catoi A, Gavrilas L, Banc R, Miere D, Filip L Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006091 PMC: 11859434. DOI: 10.3390/ph18020279.


The Many Faces of Protease-Activated Receptor 2 in Kidney Injury.

Oe Y, Tanaka T, Takahashi N Biomedicines. 2025; 13(2).

PMID: 40002827 PMC: 11852827. DOI: 10.3390/biomedicines13020414.


The Effect of Sleep Disruption on Cardiometabolic Health.

Hong S, Lee D, Yoon D, Yoo S, Kim J Life (Basel). 2025; 15(1).

PMID: 39860000 PMC: 11766988. DOI: 10.3390/life15010060.


Exosomes in Ocular Health: Recent Insights into Pathology, Diagnostic Applications and Therapeutic Functions.

Blanco-Agudin N, Ye S, Gonzalez-Fernandez S, Alcalde I, Merayo-Lloves J, Quiros L Biomedicines. 2025; 13(1).

PMID: 39857816 PMC: 11762739. DOI: 10.3390/biomedicines13010233.


The Role of Inflammation, Oxidative Stress, Neuronal Damage, and Endothelial Dysfunction in the Neuropathology of Cognitive Complications in Diabetes: A Moderation and Mediation Analysis.

Sumbul-Sekerci B, Pasin O, Balkan E, Sekerci A Brain Behav. 2025; 15(1):e70225.

PMID: 39829127 PMC: 11743999. DOI: 10.1002/brb3.70225.